Inamatsu T
Section of Infectious Disease, Tokyo Metropolitan Geriatric Hospital.
Rinsho Byori. 1993 May;41(5):557-61.
During the last 50 years, there have been changes in the types of infectious diseases causing death in Japan. Endemic diseases have decreased and nosocomial infection during the therapeutic course of various diseases have increased. Progress of various new medical technology for cancer therapy and transplantation are supported by developed infection control, and the target of microbiological tests has changed from endemic organisms to resident organisms. To manage infectious diseases, clinicians collect considerable information. Microbiological tests are only one part and sometimes are used to assess therapeutic results. In this situation, microbiological tests sometimes only reconfirm or guide changes in therapeutic strategy if the initial empiric therapy was inappropriate. Then, well designed statistical data are necessary for appropriate empiric therapy. Surveillance of hospital infection is another important role of the microbiological laboratory. To improve the functioning of the microbiological laboratory, we need not only automatic and rapid systems, but also effective communication with clinicians to respond to their needs with clinically useful data.
在过去的50年里，日本导致死亡的传染病类型发生了变化。地方病有所减少，而各种疾病治疗过程中的医院感染有所增加。癌症治疗和移植等各种新医疗技术的进步得益于发达的感染控制，微生物检测的目标已从地方病原体转变为常驻生物体。为了管理传染病，临床医生收集了大量信息。微生物检测只是其中一部分，有时用于评估治疗效果。在这种情况下，如果初始经验性治疗不合适，微生物检测有时仅用于再次确认或指导治疗策略的改变。因此，精心设计的统计数据对于适当的经验性治疗是必要的。医院感染监测是微生物实验室的另一项重要职责。为了提高微生物实验室的功能，我们不仅需要自动化和快速的系统，还需要与临床医生进行有效的沟通，以便用对临床有用的数据满足他们的需求。
